Physician profile
Carol E Salem
NPI 1336152982
$12,743.37
in general payments reported to CMS, 2019-2025
45 companies · $916 in 2025
The $916 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,275 · 2020: $684 · 2021: $1,140 · 2022: $1,116 · 2023: $4,744 · 2024: $868 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,749 · Travel and Lodging: $1,510 · Gift: $234 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,749.12 |
| Travel and Lodging | $1,510.25 |
| Gift | $233.89 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,597.46 | 2019-2025 | Da Vinci Surgical System |
| Coloplast Corp | $502.79 | 2019-2025 | Sensura Mio |
| Axonics, INC. | $473.73 | 2021-2024 | Axonics |
| Astellas Pharma US INC | $443.61 | 2019-2023 | Myrbetriq, Veozah |
| Teleflex LLC | $386.51 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $368.96 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $326.77 | 2019-2023 | Xiaflex, Aveed |
| Abbvie INC. | $282.93 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $280.45 | 2021-2025 | Imfinzi |
| Myriad Genetic Laboratories, INC. | $261.23 | 2021-2023 | Prolaris |
| Sumitomo Pharma America, INC. | $219.14 | 2023-2025 | Orgovyx, Gemtesa |
| Laborie Medical Technologies Corp. | $196.61 | 2023-2025 | |
| Neotract INC. | $192.18 | 2020 | |
| Janssen Biotech, INC. | $184.20 | 2022-2025 | Erleada |
| Pfizer INC. | $159.64 | 2019-2025 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $158.12 | 2019-2025 | Rezum Generator, Lithovue, Axonics |
| Photocure INC | $149.21 | 2019-2025 | Cysview |
| Travere Therapeutics, INC. | $144.65 | 2019-2022 | |
| Urogen Pharma, INC. | $144.02 | 2020-2025 | |
| Antares Pharma, INC. | $106.81 | 2020-2023 | Nocdurna, Tlando, Xyosted |
| Palette Life Sciences, INC. | $98.74 | 2022-2023 | |
| Myovant Sciences INC. | $94.52 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.41 | 2022-2023 | |
| Cycle Pharmaceuticals INC | $78.49 | 2025 | Venxxiva |
| 180 Medical, INC. | $73.11 | 2019-2021 | |
| Allergan, INC. | $71.42 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $71.32 | 2021-2022 | |
| Telix Pharmaceuticals | $63.71 | 2023-2024 | Illuccix |
| Progenics Pharmaceuticals, INC. | $54.38 | 2022-2023 | Pylarify |
| Ethicon US, LLC | $54.17 | 2024-2025 | Evarrest, Vistaseal, Surgicel Nu-Knit |
| Accord Healthcare, INC. | $51.47 | 2023-2024 | |
| Immunitybio, INC. | $48.05 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $40.80 | 2024-2025 | Opdivo |
| Davol INC. | $33.67 | 2024 | Phasix Mesh |
| Mimedx Group, INC. | $31.05 | 2024 | |
| Blue Earth Diagnostics | $28.34 | 2019 | |
| Biotissue Holdings INC. | $28.34 | 2025 | |
| Convatec INC. | $25.18 | 2021 | |
| Amgen INC. | $25.01 | 2019 | |
| Urovant Sciences INC | $24.55 | 2021 | |
| Endo USA, INC. | $23.86 | 2024 | Xiaflex |
| Olympus America INC. | $17.76 | 2024 | Itind System |
| Abc Home Medical Supply, INC. | $16.94 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.21 | 2019 | |
| Acerus Pharmaceuticals Corporation | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Salem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.